SYRE Competitors & Alternatives
Compare Spyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
SYRE
Main Stock$99.97
-3.88%
Tradestie Score
37
Market Cap
$994.20M
Analyst Upside
+22.7%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$38.77
-1.92%
|
$10.76B | - | 38 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$215.96
-3.32%
|
$10.74B | - | 48 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.32
+1.90%
|
$10.53B | - | 54 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$28.57
-1.70%
|
$10.49B | - | 56 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$77.18
-1.43%
|
$10.22B | - | 42 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$423.54
-0.90%
|
$10.01B | - | 48 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.79
-0.01%
|
$9.33B | 66.8 | 52 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$69.17
-5.17%
|
$8.88B | 55.4 | 50 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$97.43
-2.83%
|
$8.77B | 25.2 | 60 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$167.64
-2.70%
|
$8.57B | - | 44 | Compare |
More SYRE Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry